FTC Workshop Seeks to Spark Biosimilars Competition
By EsqSocial Corporation 07/02/14
Demand for biologics is growing fast, but even after Congress passed authorizing legislation in 2010, the pace of generic entry appears to have stalled. Seeking to spur increased generic competition, the FTC held an all-day workshop earlier this week...
By: Shearman & Sterling LLP